Skip to main content

Postdoctoral Training Opportunity – Nanomedicines for Brain Cancer Immunotherapy

Professor Chad Mirkin of the Mirkin Research Group at Northwestern is seeking highly motivated candidates for a postdoctoral position focused on developing novel therapeutics using the spherical nucleic acid (SNA) platform. In collaboration with Professor Alex Stegh of the Stegh Lab for Convergence Brain Tumour Research at Washington University in St. Louis (WashU), research efforts will be focused on SNA construct design, formulation, and implementation as immunotherapies to treat brain cancer.

This postdoctoral researcher will have a unique opportunity to be mentored by a chemist/nanoscientist (Mirkin) in the Weinberg College of Arts and Sciences (Northwestern, Evanston campus) and a brain cancer scientist (Stegh) at the Siteman Cancer Center (WashU School of Medicine in St. Louis). Together, Mirkin and Stegh have a long-standing highly interdisciplinary and productive history of collaboration.

The ideal candidates will have the following qualifications:

  • Highly motivated and professional upcoming or recent PhD or MD/PhD graduate in Chemistry, Biomedical or Chemical and Biological Engineering, or a related field (required).
  • Strong publication record in chemistry, biology, and/or cancer immunology.
  • Expertise in mouse tumor models, including syngeneic and transgenic models, and the generation of vectors and transformed cell lines.
  • Expertise in using immunological tools and assays such as FACS, extraction and analysis of splenocytes with antibodies, analysis of immune system cell stimulation and proliferation.
  • Strong communication skills and proven success working in a rigorous, fast-paced, collaborative research environment.

To apply, please send the following to Prof. Chad A. Mirkin (via

  1. a cover letter (describing your career goals and how you plan to apply your skillset to this position).
  2. a CV.
  3. and the names of at least three references (including contact information).